Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid with Radiotherapy for Osteolytic Bone Lesions
NCT00171964Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2002
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid, sponsored by Novartis. Started May 2002; status: completed.
02
Drugs
zoledronic acid
Beyond the preview
Go deeper on NCT00171964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171964.